Live Breaking News & Updates on Harpoon Therapeutics Inc

Stay updated with breaking news from Harpoon therapeutics inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Merck to Pay as Much as $3 Billion for Eye Treatment Startup

Merck to Pay as Much as $3 Billion for Eye Treatment Startup
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

United Kingdom , Kate Bingham , Sabah Meddings , Bloomberg Merck Co , Daiichi Sankyo Co , Eyebiotech Ltd , Prometheus Biosciences Inc , Sv Health Investors , Harpoon Therapeutics Inc , Daiichi Sankyo ,

Amgen Drug Wins US Approval for Advanced Small Cell Lung Cancer

Amgen Drug Wins US Approval for Advanced Small Cell Lung Cancer
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

United States , Boehringer Ingelheim Gmb , Astrazeneca Imfinzi , Jay Bradner , Robert Langreth , Bloomberg Amgen Inc , Harpoon Therapeutics Inc , Merck Co , Drug Administration , New England Journal , Harpoon Therapeutics , Boehringer Ingelheim Gmbh ,

Amgen Drug Wins US Approval for Type of Advanced Lung Cancer

Amgen Inc. won US approval for a new drug to treat a particularly aggressive form of advanced lung cancer, providing a badly needed new option for patients when chemotherapy stops working. ....

United States , Boehringer Ingelheim Gmb , Astrazeneca Imfinzi , Robert Langreth , Jay Bradner , Drug Administration , Merck Co , Harpoon Therapeutics Inc , New England Journal , Harpoon Therapeutics , Boehringer Ingelheim Gmbh ,

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer

Viracta Therapeutics Appoints Michael Faerm as Chief Financial Officer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Ashleigh Barreto , Michael Faerm , Mark Rothera , Theravance Inc , Viracta Therapeutics Inc , Stanford University , Regeneron Pharmaceuticals , Harvard Business School , Harpoon Therapeutics Inc , Artiva Biotherapeutics Inc , Merrill Lynch , Head Of Investor Relations Corporate Communications , Columbia University , Credit Suisse , Innoviva Inc , Therapeutics Appoints Michael Faerm , Chief Financial , Chief Financial Officer , Wall Street , Chief Executive Officer , Interim Chief Financial Officer , Harpoon Therapeutics , Chief Business Officer , Forest Laboratories , Wells Fargo Securities , Viracta Therapeutics ,

Merck Announces First-Quarter 2024 Financial Results

Sales Reflect Continued Strong Growth in Oncology and Vaccines

Total Worldwide Sales Were $15.8 Billion, an Increase of 9% From First Quarter 2023; Excluding the Impact of Foreign Exchange,. ....

United States , Adempas Verquvo , Raludotatug Deruxtecan , Robertm Davis , Daiichi Sankyo , Harpoon Therapeutics Inc , European Commission Approved Merck , Alliance Revenue , Gilead Sciences Inc , World Health Organization Group , Animal Health , European Union , Drug Administration , Elanco Animal Health Incorporated , Statement Of Merck Co Inc , Net Income Attributable To Merck Co Inc , Merck Co Inc , Imago Biosciences Inc , Merck Co , Exchange Commission , Accepted Accounting Principles , Harpoon Therapeutics , Imago Biosciences , Asia Pacific , Latin America , Companion Animal ,